Outcomes of radical surgical resections for nonmetastatic anorectal melanomas: Experience from a tertiary care centre.
Ambarish ChatterjeeJitender RohilaMufaddal M KaziVivekanand SharmaAshwin DesouzaVikas OstwalJyoti BajpaiReena EngineerMunita BalAvanish P SaklaniPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2021)
In this large surgical series of AMs, outcome in stage I and II patients was significantly better than stage III and patients with stage II disease can have acceptable oncological outcomes. Radical surgical resections with or without lymphadenectomy could be considered in these patients. The role of adjuvant systemic therapy and radiation needs to be explored as part of multimodality treatment.
Keyphrases
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- early stage
- prognostic factors
- tertiary care
- peritoneal dialysis
- prostate cancer
- type diabetes
- metabolic syndrome
- patient reported outcomes
- mesenchymal stem cells
- lymph node metastasis
- insulin resistance
- radical prostatectomy
- skeletal muscle
- combination therapy
- patient reported
- minimally invasive
- glycemic control
- replacement therapy